PLASMATECH BIOPHARMACEUTICALS INC — Form D
PLASMATECH BIOPHARMACEUTICALS INC of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-02. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-11-02
- Form: D
- Accession: 0001140361-12-045375
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 1
- Date of first sale: 2012-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-186444
Issuer
- Name: PLASMATECH BIOPHARMACEUTICALS INC
- CIK: 0000318306
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2600 N STEMMONS FRWY, DALLAS, TX, 75207
- Phone: 2149055100
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Mark J Ahn, Ph.D. | Director | Portland, OR |
| Jeffrey B Davis | Director | Addison, TX |
| Stephen B Howell, M.D. | Director | Dallas, TX |
| Steven H Rouhandeh | Director | Dallas, TX |
| Jeffrey B Davis | Executive Officer | Addison, TX |
| Stephen B Thompson | Promoter | Dallas, TX |
| Todd B Wider | Director | Gladwyne, PA |
| Stephen B Howell | Director | Dallas, TX |
| Jeffrey H Davis | Director | Dallas, TX |
| Tim B Miller | Director | Dallas, TX |
| Tim B Miller | Executive Officer | Dallas, TX |
| Steven H Rouhandeh | Executive Officer | Dallas, TX |
| Stephen B Thompson | Executive Officer | Dallas, TX |
| Mark J Alvino | Director | Dallas, TX |
| Todd B Widder | Director | Dallas, TX |
| Mark J Ahn | Director | Portland, OR |
| Esteban H Cvitkovic, M.D. | Director | Dallas, TX |
Other filings by this issuer (3)
More